Cargando…
Response to: ‘TARA Study: a new perspective on tapering drugs in RA’ by Mishra et al
Autores principales: | van Mulligen, Elise, Hazes, Johanna M W, Weel, Angelique E A M, de Jong, Pascal H P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7307212/ https://www.ncbi.nlm.nih.gov/pubmed/31110029 http://dx.doi.org/10.1136/annrheumdis-2019-215641 |
Ejemplares similares
-
Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020) -
Two-year cost effectiveness between two gradual tapering strategies in rheumatoid arthritis: cost-utility analysis of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020) -
Response to the letter by Esteves et al.
por: Send, T. S., et al.
Publicado: (2018) -
Reply to L. Yaghjyan et al.
por: Deshmukh, Ashish A, et al.
Publicado: (2018) -
Response to Bell et al.
por: Weiner, Orion
Publicado: (2014)